Building a cross-border pharmaceutical supply partnership

A leading Korean pharmaceutical company was preparing to strengthen the global supply network for one of its key products. To support continued commercialisation and future international expansion, it needed an additional API manufacturing partner, one with the technical capability, production capacity, quality systems and regulatory support to serve several markets at once.

Finding a manufacturer was the smallest part of the problem. The project required technology transfer, manufacturing scale-up, demand forecasting, regulatory requirements, quality responsibilities, commercial expectations and long-term supply planning to be coordinated across companies operating in different countries.

Kyodo bridged the commercial and operational relationship between the Korean pharmaceutical company and a qualified Indian API manufacturer.

Working alongside our Korean partner, we acted as the central coordination and commercial interface between the two companies: keeping the technical, commercial, regulatory and supply discussions aligned with each other as the partnership took shape.

Rather than treating the project as a conventional buyer–supplier transaction, Kyodo helped establish a long-term strategic manufacturing partnership.

The resulting framework made the Indian manufacturer a key manufacturing partner, and built in mechanisms for long-range and rolling demand forecasts, production planning, quality management, regulatory cooperation and future supply expansion.

That structure gives the pharmaceutical company visibility over future manufacturing capacity, and gives the manufacturer the ability to plan production as commercialisation expands. Kyodo remains positioned between the parties: coordinating communication, resolving commercial and operational issues, and supporting the relationship as it continues to develop.

The partnership was structured not only to meet existing commercial requirements but to provide a foundation for expansion into additional regulated markets, including Japan, Europe and the United States.

By connecting pharmaceutical technology and commercial demand with capable Indian manufacturing, Kyodo helps partners build supply networks that grow alongside their international business.